Congenital CMV: Difference between revisions
From IDWiki
Content deleted Content added
m →Clinical Presentation: semantic links |
|||
| Line 10: | Line 10: | ||
* Mother may have had asymptomatic infection |
* Mother may have had asymptomatic infection |
||
* At birth |
* At birth |
||
** Microcephaly |
** [[Causes::Microcephaly]] |
||
** Periventricular calcifications |
** [[Causes::Periventricular calcifications]] |
||
** Chorioretinitis |
** [[Causes::Chorioretinitis]] |
||
** Sensorineural hearing loss |
** [[Causes::Sensorineural hearing loss]] |
||
** Optic nerve atrophy |
** [[Causes::Optic nerve atrophy]] |
||
** Hepatosplenomegaly |
** [[Causes::Hepatosplenomegaly]] |
||
** [[Causes::Cytopenias]] |
|||
** Cytopenia |
|||
* Later |
* Later |
||
** Cognitive deficits (7%) |
** [[Causes::Cognitive deficits]] (7%) |
||
** Sensorineural hearing loss (20%) |
** [[Causes::Sensorineural hearing loss]] (20%) |
||
== Diagnosis == |
== Diagnosis == |
||
Revision as of 15:07, 8 February 2020
Epidemiology
- Risk of transmission to fetus
- Primary infection: 30% risk of congenital CMV; higher risk later in pregnancy, but worse outcomes earlier
- Non-primary
- Reinfection: 5% risk
- Reactivation: 1% risk
Clinical Presentation
- Mother may have had asymptomatic infection
- At birth
- Later
- Cognitive deficits (7%)
- Sensorineural hearing loss (20%)
Diagnosis
- In mom, IgM antibodies
- In baby, urine PCR within 2 weeks of birth
Management
- Treatment is indicated for symptomatic babies
- Brain
- Hearing
- Eye
- IV ganciclovir or PO valganciclovir, for 6 months
- Monitor CBC while on therapy
References
- ^ Gisela Enders, Anja Daiminger, Ursula Bäder, Simone Exler, Martin Enders. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. Journal of Clinical Virology. 2011;52(3):244-246. doi:10.1016/j.jcv.2011.07.005.
